Recombinant human growth hormone(Baylor College of Medicine)

重组人生长激素（贝勒医学院）

Report date: 2022/05/12 18:06:27

Base Information

Drug NameRecombinant human growth hormone(Baylor College of Medicine)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormoneBiologics > Biosimilar
Mechanisms of ActionGrowth hormone receptor agonists
TargetsGrowth hormone receptor
Therapy Area/IndicationsGrowth hormone deficiencyPersian Gulf Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBaylor College Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesBaylor College Of Medicine
Inactive CompaniesN/A
Active IndicationsGrowth hormone deficiencyPersian Gulf Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A